Abstract
Cardiovascular diseases remain one of the main causes of hospitalization, disability, and mortality. The usual monitoring model and rare face-to-face visits often do not keep up with the actual clinical dynamics. This partly explains the growing interest in wearable devices and telemedicine support formats. The doctor no longer has individual measurements at his disposal, but sequential physiological series of data on rhythm, heart rate, motor activity, sleep, and in some cases, electrocardiographic parameters. The scenarios related to the detection of atrial fibrillation, telemonitoring for heart failure, telerehabilitation for coronary heart disease, and assessment of functional status based on daily activity data are the best studied today. However, the clinical value of these technologies is determined not by the fact of their use, but by the degree of validation of the received signals, the quality of data inclusion in the treatment route, and the doctor’s ability to distinguish significant changes from digital noise. Within the framework of personalized medicine, wearable devices should be considered as a source of additional information about the patient’s phenotype, including reflecting the state of autonomous regulation, the inflammatory background, signs of endothelial dysfunction, processes of myocardial remodeling and neurohumoral shifts. However, the direct integration of digital parameters with molecular biomarkers is currently used mainly in scientific research, without proper development in clinical practice.
Keywords
Authors and affiliations
https://elibrary.ru/pkmgep
P.V. Seliverstov(1), S.P. Salikova(1), V.N. Fedorets(2), V.P. Kutsenko(2), A.A. Shevyakov(3), I.A. Samarskiy(3), N.M. Levitskiy(4), K.A. Akhmad(4)
1-S.M. Kirov Military Medical Academy of the Ministry of Defense of the Russian Federation, Akademika Lebedeva Street, 6, Saint-Petersburg, 194044, Russian Federation; 2-Saint-Petersburg State Pediatric Medical University of the Ministry of Health of the Russian Federation,
Russian Federation, 194100, Saint-Petersburg, Litovskaya str., 2; 3N.I. Pirogov Russian National Research Medical University,
Ministry of Health of the Russian Federation, Russian Federation, 117513, Moscow, Ostrovityanova str., 1, building 6; 4-The State Education Institution of Higher Professional Training The First Sechenov Moscow State Medical University under Ministry of Health
of the Russian Federation, Trubetskaya street, 8/2, Moscow, 119992, Russian Federation
References
McDonagh T.A., Metra M., Adamo M., Gardner R.S., Baumbach A., Böhm M. et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021; 42 (36): 3599–726. DOI: 10.1093/eurheartj/ehab368.
2. McDonagh T.A., Metra M., Adamo M., Gardner R.S., Baumbach A., Böhm M. et al. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 2023; 44 (37): 3627–39. DOI: 10.1093/eurheartj/ehad195.
3. Van Gelder I.C., Rienstra M., Bunting K.V., Casado-Arroyo R., Caso V., Crijns H.J.G.M. et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 2024; 45 (36): 3314–414. DOI: 10.1093/eurheartj/ehae176.
4. Jensen M.T., Holtermann A., Bay H. et al. ESC working group on e-cardiology position paper: use of commercially available wearable technology for heart rate and activity tracking in primary and secondary cardiovascular prevention. Eur. Heart J. Digit Health. 2021. DOI: 10.1093/ehjdh/ztab011.
5. Svennberg E., Tjong F., Goette A., Akoum N., Di Biase L., Bordachar P. et al. How to use digital devices to detect and manage arrhythmias: an EHRA practical guide. Europace. 2022; 24 (6): 979–1005. DOI: 10.1093/europace/euac038.
6. Linz D., Vandenberk B., Saitoh Y., Hermans A., Manninger M., Haeusler K.G. et al. Atrial fibrillation: epidemiology, screening and digital health. Lancet Reg Health Eur. 2024; 37: 100786. DOI: 10.1016/j.lanepe.2023.100786.
7. Perez M.V., Mahaffey K.W., Hedlin H., Rumsfeld J.S., Garcia A., Ferris T. et al. Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation. N. Engl. J. Med. 2019; 381 (20): 1909–17. DOI: 10.1056/NEJMoa1901183.
8. Turakhia M.P., Desai M., Hedlin H., Rajmane A., Talati N., Ferris T. et al. Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: The Apple Heart Study. Am. Heart J. 2019; 207: 66–75. DOI: 10.1016/j.ahj.2018.09.002.
9. Guo Y., Wang H., Zhang H., Liu T., Liang Z., Xia Y. et al. Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation. J. Am. Coll. Cardiol. 2019; 74 (19): 2365–75. DOI: 10.1016/j.jacc.2019.08.019.
10. Lubitz S.A., Faranesh A.Z., Selvaggi C., Atlas S.J., McManus D.D., Singer D.E. et al. Detection of Atrial Fibrillation in a Large Population Using Wearable Devices: The Fitbit Heart Study. Circulation. 2022; 146 (19): 1415–24. DOI: 10.1161/CIRCULATIONAHA.122.060291.
11. Mannhart D., Badertscher P., Boeddinghaus J., Nestelberger T., Twerenbold R., Wildi K. et al. Clinical Validation of 5 Direct-to-Consumer Wearable Smart Devices to Detect Atrial Fibrillation: BASEL Wearable Study. JACC Clin Electrophysiol. 2023; 9 (2): 232–42. DOI: 10.1016/j.jacep.2022.09.011.
12. Wasserlauf J., You C., Patel R., Valys A., Albert D., Passman R. Smartwatch Performance for the Detection and Quantification of Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2019; 12 (6): e006834. DOI: 10.1161/CIRCEP.118.006834.
13. Kim J.Y., Kim S.H., Kim Y.G. et al. The efficacy of detecting arrhythmia is higher with 7-day continuous electrocardiographic patch monitoring than with 24-h Holter monitoring. J. Arrhythm. 2023; 39 (3): 422–9. DOI: 10.1002/joa3.12865.
14. Svendsen J.H., Diederichsen S.Z., Højberg S., Krieger D.W., Graff C., Kronborg C. et al. Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial. Lancet. 2021; 398 (10310): 1507–16. DOI: 10.1016/S0140-6736(21)01698-6.
15. Koehler F., Koehler K., Deckwart O., Prescher S., Wegscheider K., Kirwan B.A. et al. Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial. Lancet. 2018; 392 (10152): 1047–57. DOI: 10.1016/S0140-6736(18)31880-4.
16. Chaudhry S.I., Mattera J.A., Curtis J.P., Spertus J.A., Herrin J., Lin Z. et al. Telemonitoring in Patients with Heart Failure. N. Engl. J. Med. 2010; 363 (24): 2301–9. DOI: 10.1056/NEJMoa1010029.
17. Ong M.K., Romano P.S., Edgington S., Aronow H.U., Auerbach A.D., Black J.T. et al. Effectiveness of Remote Patient Monitoring After Discharge of Hospitalized Patients With Heart Failure: The BEAT-HF Randomized Clinical Trial. JAMA Intern Med. 2016; 176 (3): 310–8. DOI: 10.1001/jamainternmed.2015.7712.
18. Piotrowicz E., Pencina M.J., Opolski G., Zareba W., Banasiak W., Kowalik I. et al. Effects of a 9-week hybrid comprehensive telerehabilitation program on long-term outcomes in patients with heart failure: The TELEREH-HF randomized clinical trial. JAMA Cardiol. 2020; 5 (3): 300–8. DOI: 10.1001/jamacardio.2019.5006.
19. Piotrowicz E., Baranowski R., Bilinska M., Stepnowska M., Piotrowska M., Wójcik A. et al. A new model of home-based telemonitored cardiac rehabilitation in patients with heart failure: effectiveness, quality of life, and adherence. Eur. J. Heart Fail. 2010; 12 (2): 164–71. DOI: 10.1093/eurjhf/hfp181.
20. Stehlik J., Schmalfuss C., Bozkurt B., Nativi-Nicolau J., Wohlgemuth J., Wegerich S. et al. Continuous Wearable Monitoring Analytics Predict Heart Failure Hospitalization: The LINK-HF Multicenter Study. Circ Heart Fail. 2020; 13 (3): e006513. DOI: 10.1161/CIRCHEARTFAILURE.119.006513.
21. Zito A., Prinz C., Maier L.S. et al. Device-based remote monitoring strategies for congestion-guided management of patients with heart failure: a systematic review and meta-analysis. Eur. J. Heart Fail. 2022; 24 (12): 2333–41. DOI: 10.1002/ejhf.2655.
22. Javaid S.S., Siddiqi T.J. et al. Remote Monitoring in Heart Failure patients: A Systemic Review and Meta-analysis. Curr Probl Cardiol. 2023; 48 (6): 101635. DOI: 10.1016/j.cpcardiol.2023.101635.
23. Gao Y., Wang N., Zhang L., Liu N. Effectiveness of home-based cardiac telerehabilitation in patients with heart failure: A systematic review and meta-analysis of randomised controlled trials. J. Clin. Nurs. 2023; 32 (21–22): 7661–76. DOI: 10.1111/jocn.16726.
24. Wongvibulsin S., Habeos E.E., Huynh P.P., Xun H., Shan R., Porosnicu Rodriguez K.A. et al. Digital Health Interventions for Cardiac Rehabilitation: Systematic Literature Review. J. Med. Internet Res. 2021; 23 (2): e18773. DOI: 10.2196/18773.
25. Jones A.K., Yan C.L., Rivera Rodriquez B.P., Kaur S., Andrade-Bucknor S. Role of wearable devices in cardiac telerehabilitation: A scoping review. PLoS One. 2023; 18 (5): e0285801. DOI: 10.1371/journal.pone.0285801.
26. Ferguson C., Hickman L.D., Turkmani S., Breen P., Gargiulo G., Inglis S.C. “Wearable devices only work on patients that wear them”: Barriers and facilitators to the adoption of wearable cardiac monitoring technologies. Cardiovasc Digit Health J. 2021; 2 (2): 137–47. DOI: 10.1016/j.cvdhj.2021.02.001.
27. Demkowicz P.C., Dhruva S.S., Spatz E.S., Beatty A.L., Ross J.S., Khera R. Physician responses to apple watch-detected irregular rhythm alerts. Am. Heart J. 2023; 262: 29–37. DOI: 10.1016/j.ahj.2023.04.008.
28. Stergiou G.S. et al. European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability recommendations for the validation of intermittent cuffless blood pressure devices. J. Hypertens. 2023.
29. Tan I., Sharman J.E. et al. Evaluation of the ability of a commercially available cuffless wearable device to track blood pressure changes. J. Hypertens. 2023.
30. Zhang W., Zhang M., He J. et al. Validation of a watch-type blood pressure monitor (HUAWEI WATCH D) according to the ANSI/AAMI/ISO 81060-2:2018 protocol in adults in China. Blood Press Monit. 2022; 27 (5): 353–6. DOI: 10.1097/MBP.0000000000000608.
31. Williams D.P., Koenig J., Carnevali L., Sgoifo A., Jarczok M.N., Sternberg E.M., Thayer J.F. Heart rate variability and inflammation: A meta-analysis of human studies. Brain Behav Immun. 2019; 80: 219–26. DOI: 10.1016/j.bbi.2019.03.009.
32. Jiang Y. et al. The role of age-associated autonomic dysfunction, inflammation, and endothelial dysfunction in cardiovascular disease. GeroScience. 2022.
33. Corban M.T., Lerman L.O., Lerman A. Atrial Fibrillation and Endothelial Dysfunction: A Potential New Pathophysiologic Axis? Circ Res. 2021.
34. Fabritz L., Chung W.H., Kirchhof P. et al. Blood-based cardiometabolic phenotypes in atrial fibrillation. Cardiovasc Res. 2024. DOI: 10.1093/cvr/cvae067.
35. Siontis K.C., Noseworthy P.A., Attia Z.I., Friedman P.A. Artificial intelligence-enhanced electrocardiography in cardiovascular disease management. Nat Rev Cardiol. 2021; 18 (7): 465–78. DOI: 10.1038/s41569-020-00503-2.
36. Golbus J.R., Gosch K., Birmingham M.C., Butler J., Lingvay I., Lanfear D.E. et al. Association Between Wearable Device Measured Activity and Patient-Reported Outcomes for Heart Failure. JACC Heart Fail. 2023; 11 (11): 1521–30. DOI: 10.1016/j.jchf.2023.05.033.
37. Tinggaard A.B., Sørensen L., Vissing K., Jessen N., Nørrelund H., Wiggers H. Daily physical activity and prognostic implications in patients with heart failure: an accelerometer study. Clin Res Cardiol. 2025; 114 (5): 616–28. DOI: 10.1007/s00392-024-02508-0.
38. Docherty K.F. et al. Wearable Accelerometer-Derived Measures of Physical Activity in Patients With Heart Failure. 2025.
39. Alam S. et al. The Impact of Consumer Wearable Devices on Physical Activity and Adherence to Physical Activity in Patients with Cardiovascular Disease: A Systematic Review of Systematic Reviews and Meta-Analyses. Telemed J. E Health. 2023; 29 (7): 986–1000. DOI: 10.1089/tmj.2022.0280.
40. Stergiou G.S., Mukkamala R., Avolio A. et al. Cuffless blood pressure measuring devices: review and statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability. J. Hypertens. 2022; 40: 1449–60.
41. Mukkamala R., Hahn J.O., Inan O.T., Mestha L.K., Kim C.S., Töreyin H. et al. Evaluation of the Accuracy of Cuffless Blood Pressure Measurement Devices: Challenges and Proposals. Hypertension. 2021.
42. Mukkamala R., Shroff S.G., Landry C., Kyriakoulis K.G., Avolio A.P., Stergiou G.S. Important Findings on Cuffless Blood Pressure Measurement. Hypertension. 2023. DOI: 10.1161/HYPERTENSIONAHA.122.20410.
43. Каменская О.В., Логинова И.Ю., Клинкова А.С. и др. Телемедицинские системы в кардиореабилитации: обзор современных возможностей и перспективы применения в клинической практике. Российский кардиологический журнал. 2020; 25 (6): 3365. DOI: 10.15829/1560-4071-2020-3365. [Kamenskaya O.V., Loginova I.Yu., Klinkova A.S. et al. Telemedicine systems in cardiac rehabilitation: a review of current capabilities and prospects for clinical application. Rossiyskiy kardiologicheskiy J. 2020; 25 (6): 3365. DOI: 10.15829/1560-4071-2020-3365 (in Russian)].
44. Видяева Н.Г., Солодухин А.В., Помешкина С.А., Зверева Т.Н. Возможности применения телемедицинских технологий в реабилитации пациентов с сердечно-сосудистыми заболеваниями. Профилактическая медицина. 2021; 24 (3): 95–9. DOI: 10.17116/profmed20212403195. [Vidyaeva N.G., Solodukhin A.V., Pomeshkina S.A., Zvereva T.N. Possibilities of using telemedicine technologies in rehabilitation of patients with cardiovascular diseases. Profilakticheskaya meditsina. 2021; 24 (3): 95–9. DOI: 10.17116/profmed20212403195 (in Russian)].
45. Лямина Н.П., Харитонов С.В. Цифровые носимые устройства в кардиореабилитации: потребность пациентов и удовлетворенность. Обзор литературы. КардиоСоматика. 2022; 13 (1): 23–30. [Lyamina N.P., Kharitonov S.V. Digital wearable devices in cardiac rehabilitation: patient needs and satisfaction. A literature review. KardioSomatika. 2022; 13 (1): 23–30 (in Russian)].
46. Koehler F., Koehler K., Deckwart O., Prescher S., Wegscheider K., Kirwan B.A. et al. Mortality and morbidity 1 year after stopping a remote patient management intervention in patients with heart failure: extended follow-up results from the TIM-HF2 trial. Eur. J. Heart Fail. 2020.
47. Селиверстов П.В., Крюков Е.В., Гриневич В.Б. Практическая реализация технологий искусственного интеллекта при проведении профилактического медицинского осмотра. Медицинский Совет. 2025; 19 (13): 282–8. https://doi.org/10.21518/ms2025-322. [Seliverstov P.V., Kryukov E.V., Grinevich V.B. Practical implementation of artificial intelligence technologies during preventive medical examinations. Medical Council. 2025; 19 (13): 282–8. https://doi.org/10.21518/ms2025-322 (in Russian)].